According to the 2025 American Heart Association (AHA) guidelines, what is the maximum bolus dose of unfractionated heparin (UFH) that should be administered, even when percutaneous coronary intervention (PCI) is planned?

Maximum UFH Bolus Dose in ACS with Planned PCI

You are correct—the 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines explicitly state a maximum bolus dose of 4,000 IU for unfractionated heparin in acute coronary syndromes, even when PCI is planned. 112

Key Dosing Distinctions

The guidelines clearly differentiate between initial medical therapy and procedural anticoagulation to support PCI:

Initial Medical Therapy (Pre-PCI or Medical Management)

• Loading dose: 60 IU/kg with a maximum cap of 4,000 IU
• Initial infusion: 12 IU/kg/hour (maximum 1,000 IU/hour)
• Target aPTT: 60-80 seconds
• This applies whether fibrinolytic therapy is used or not 112

To Support PCI (At Time of Procedure)

For patients who have NOT received prior anticoagulant therapy:

• 70-100 U/kg initial bolus (note: no maximum cap specified here)
• Target ACT: 250-300 seconds 112

For patients who HAVE received prior anticoagulant therapy:

• Additional UFH as needed to achieve ACT 250-300 seconds 112

Clinical Implications

The 4,000 IU maximum applies specifically to the initial medical management bolus, not to the procedural bolus given at the time of PCI. This is a critical distinction that prevents underdosing in the catheterization laboratory.

Common Pitfall to Avoid

Do not confuse the initial medical therapy dose (capped at 4,000 IU) with the procedural dose for PCI. If a patient presents with ACS and receives initial UFH therapy with the 4,000 IU cap, they will likely require additional heparin in the cath lab to achieve therapeutic ACT levels of 250-300 seconds 112.

Why This Matters

Research demonstrates that over half of patients receiving standard bolus doses fail to achieve therapeutic ACT levels during PCI 34. The 70-100 U/kg procedural dose (without a cap) is designed to address this variability and ensure adequate anticoagulation during the intervention itself.

The evidence shows that higher maximum doses during PCI achieve therapeutic anticoagulation more rapidly without increasing bleeding risk 5, supporting the guideline's approach of removing the cap for procedural dosing.

Practical Algorithm

1. At presentation/admission for ACS: Give 60 IU/kg UFH bolus (max 4,000 IU) + infusion
2. At time of PCI:
   • If already on UFH infusion → titrate additional UFH to ACT 250-300 seconds
   • If no prior anticoagulation → give 70-100 U/kg bolus (no cap) targeting ACT 250-300 seconds

The FDA labeling supports cardiovascular surgery doses of 300-400 U/kg without specific caps 6, further validating that the 4,000 IU maximum is context-specific to initial medical therapy rather than procedural anticoagulation.

Tokens used this turn: 27526 (this turn) / 200000 (budget) Tokens used total: 27526 / 200000